WHO ICTRP trial
FLORAL: A research study looking at long-term treatment with etavopivat in…
PACTR202408476236496 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202408476236496 |
|---|---|
| Public title | FLORAL: A research study looking at long-term treatment with etavopivat in people with sickle cell disease or thalassaemia |
| Scientific title | An open-label, multi-centre, rollover study to characterise long-term safety andefficacy of etavopivat in adults, adolescents and children who have sickle cell disease orthalassaemia and have completed a treatment period in an etavopivat study |
| Primary sponsor | Novo Nordisk |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-3 |
| Countries | Ghana;Ghana;Kenya;Kenya;Kenya;Kenya;Kenya;Kenya |
| Conditions | Haematological Disorders |
| Registration date | Aug 7, 2024 |
| Target size | 325 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: